Hantaviruses cause hemorrhagic fever with renal syndrome (HFRS) in Europe and Asia. Interferon (IFN) responses play an important role in HFRS pathogenesis and early IFN-β response is delayed by pathogenic hantaviruses. The severity of HFRS caused by Dobrava virus (DOBV) and Puumala virus (PUUV) varies. Our aim was to determine whether differences in early activation of IFN type 1-induced antiviral state influence HFRS severity. Peripheral blood mononuclear cells (PBMCs) from healthy donors and HFRS patients were stimulated with DOBV or PUUV and expression of selected genes was measured. PUUV, but not DOBV, activated IFN type 1-induced antiviral state in stimulated PBMCs, and IFNβ, STAT-1, and MxA were highly upregulated. Upregulation of MxA was earlier in acute-phase PBMCs and higher in convalescent-phase PBMCs from patients with mild compared with severe PUUV infection. Our study showed that delayed IFN type 1-induced antiviral state could contribute to HFRS severity, particularly in PUUV infection.
Hantaviruses are present globally and cause 2 typical syndromes: hemorrhagic fever with renal syndrome (HFRS) in Europe and Asia, and hantavirus cardiopulmonary syndrome in the Americas. HFRS is an endemic disease in Slovenia and is caused by Dobrava virus (DOBV) and Puumala virus (PUUV); DOBV is mainly responsible for more severe disease, whereas PUUV usually causes a milder form. However, the clinical severity of HFRS varies greatly and in Slovenia both severe and mild clinical courses of the disease have been observed, with an overall case fatality rate of 4.5% [1, 2] .
Hantavirus infection triggers innate immune responses, and immunopathogenic factors such as the interferon (IFN) response play an important role in the pathogenesis of HFRS. The type 1 IFN system is considered a major component of defense against virus infections. Expression of type 1 IFNs is regulated by activation of interferon regulatory factor 3 (IRF3) and nuclear factor κB (NFκB), which in turn transactivate the expression of IFN-β. Binding of the IFNs to type 1 IFN-specific receptors activates the JAK-STAT signaling pathway, leading to expression of several IFN-stimulated genes (ISGs) [3] . Expression of these genes results in establishment of an antiviral state that protects cells against infection with hantaviruses.
Most studied has been the MxA protein, which interferes with intracellular transport of the nucleocapsid protein of several viruses and prevents its accumulation at sites of virus assembly [4] [5] [6] .
Pathogenic hantaviruses interact with the early steps of the IFN antiviral pathway and delay transcription of IFNβ and ISGs, thus enabling early viral replication and spread of infection [7] . Nevertheless, the supposedly nonpathogenic Tula virus has been shown to regulate IFN response [8] , suggesting that IFN regulation is not sufficient for hantaviruses to be human pathogens. Hantavirus pathogenesis is likely to be a complex multifactorial process that includes contributions from immune responses, platelet dysfunction, and the deregulation of endothelial cell barrier functions [9] . The individual immune response might also be an important factor for severity of HFRS, and a genetic predisposition towards severe HFRS disease has been related to HLA type [10] .
The complete role of the IFN type 1 response in HFRS pathogenesis remains unknown. The aim of our study was to investigate differences in activation of the response in human peripheral blood mononuclear cells (PBMCs) in early poststimulation with DOBV or PUUV and to determine whether the observed difference in the IFN type 1-induced antiviral state is associated with HFRS severity.
METHODS
The study was approved by the Republic of Slovenia National Medical Ethics Committee (69/03/12 and 30/04/15). All participants gave oral and written informed consent. The study
M A J O R A R T I C L E
was conducted according to the principles expressed in the Declaration of Helsinki.
HFRS Patients and Healthy Donors
A total of 24 patients with confirmed HFRS, hospitalized in different Slovenian hospitals, were included in this study. Clinical diagnosis was confirmed serologically by: an indirect immunofluorescence assay (IFA), enzyme-linked immunoassay IgM and IgG tests (ELISA), and 1-step quantitative real time polymerase chain reaction (RT-PCR ) assay, as described previously [1, 11, 12] . For each patient a detailed medical chart was collected and significant laboratory parameters were analyzed. Patients were categorized into 2 groups: mild and severe disease, based on clinical data and laboratory parameters. Patients with thrombocytopenia <50 × 10 9 /L, the need for hemodialysis, or having >2 of the following criteria: bleeding, oliguria/anuria, and levels of urea and/or creatinine at least 4 times higher than the upper normal level, were classified as severe disease. Patients without the above mentioned criteria were classified to the mild disease group. In addition, 8 healthy donors (3 female, 5 male, aged between 18 and 58 years) were included in the study.
Isolation of PBMCs
PBMCs from ethylenediaminetetraacetic acid (EDTA) blood samples of healthy donors and patients were purified using Ficoll-Paque PLUS (GE Healthcare, Uppsala, Sweden) density gradient centrifugation on Leucosep tubes (Greiner Bio-One, GmbH, Germany) according to the manufacturer's instructions. Isolated PBMCs were resuspended in RPMI 1640 (Sigma, UK) with 80% fetal bovine serum (EuroClone, Pero, Italy) and 10% dimethyl sulfoxide, and cryopreserved until further analysis.
In Vitro Stimulation of PBMCs
PBMCs were thawed and resuspended in RPMI 1640 with 10% inactivated human serum (Sigma, UK), 1% l-glutamine (Gibco, UK), and 2% antibiotics (penicillin 100 U/mL, streptomycin 0.1 mg/mL). The final concentration of PBMCs was 5 × 10 5 cells/ mL in a single well of a 24-well plate (Costar, Buckinghamshire, UK). Hantaviruses DOBV and PUUV were grown on a VERO E6 cell line and were tested to be Mycoplasma free (ATCC commercial kit). Viruses were cleaned through NAP-5 columns prepacked with Sephadex G-25 DNA grade resin (Illustra, GE Healthcare) and resuspended in saline. PBMCs were stimulated with DOBV or PUUV at multiplicity of infection 0.1 and incubated at 37°C with 5% CO 2 for 1, 3, 6, 9, 12, 16, 24, and 48 hours. PBMCs isolated from patients infected with DOBV were stimulated with DOBV, and PBMCs isolated from patients infected with PUUV were stimulated with PUUV.
Quantitative Real-Time RT-PCR
To determine changes in gene expression, TaqMan Gene Expression Assays (Thermo Fischer Scientific, CA) were used according to the manufacturer's instructions. IFNβ (Assay ID Hs01077958_s1), NFkB (Assay ID Hs00765730_m1), STAT-1 (Assay ID Hs01013996_m1), and MxA (Assay ID Hs00895608_ m1) were measured. In addition, GAPDH (Assay ID Hs03929097_ g1) and GUSB (Assay ID Hs00939627_m1) were measured as housekeeping control genes. RNA was isolated from stimulated PBMCs using the RNeasy mini kit with on-column DNase digestion (Qiagen, GmbH, Hilden, Germany) according to the manufacturer's protocol. cDNA was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City). The TaqMan Universal Master Mix II with UNG was used for RT-qPCR assays (Applied Biosystems, Foster City). Quantitative PCR was used to test each sample in triplicate. Gene expression values of nonstimulated cells were used for gene expression calibration. Normalized relative quantities were calculated using double delta Ct (2 -ΔΔCt ) analysis [13] .
Statistical Analysis
GraphPad Prism version 6 for Windows (GraphPad Software, San Diego, CA) was used for the analyses. Differences between groups were calculated using the nonparametric MannWhitney U test. All statistical tests were 2-tailed. A P value below 0.05 was considered significant.
RESULTS

Patients and Clinical Data
PBMCs were isolated from EDTA blood samples of the 24 HFRS patients during the acute phase of infection (mean on fifth day of hospitalization). Among them, 11 patients were infected with DOBV and 13 with PUUV. In all patients, acute DOBV or PUUV infection was established with detection of IgM and IgG-specific antibody and confirmed with detection of DOBV or PUUV RNA with real time RT-PCR. Seven patients infected with DOBV had the severe form of the disease and 4 the mild form; 4 patients infected with PUUV had severe disease and 9 the mild form. Convalescent-phase PBMCs were isolated from 19 of the 24 patients between 1 and 7 years (mean 4 years) after the acute infection. Among these, 7 patients were infected with DOBV (4 severe, 3 mild) and 12 with PUUV (4 severe, 8 mild).
PUUV, but not DOBV, Stimulates High Activation of the IFN Type 1-Induced Antiviral State in PBMCs From Healthy Donors
To determine activation of the early IFN type 1 response by DOBV and PUUV, we stimulated PBMCs from healthy donors and compared the expression of genes IFNβ, NFκB, STAT-1, and MxA poststimulation with the 2 viruses. Our findings indicated a significantly higher IFN type 1-induced antiviral state at 48 hours poststimulation with PUUV than with DOBV (Supplementary Table 1 ); expression of IFNβ was 3-fold higher poststimulation with PUUV (P = .04) (Figure 1 ). Our results showed that DOBV inhibited the early IFNβ response in human PBMCs. Moreover, PUUV also delayed the expression of early IFNβ and its significant upregulation was detected only at 48 hours poststimulation. We also measured expression of transcription factor NFκB and found no significant upregulation of the gene poststimulation with either of the viruses (Figure 1 ). Expression of STAT-1 was 3-fold higher poststimulation with PUUV than with DOBV (P = .03) (Figure 1 ). To determine activation of the type 1 IFN-induced antiviral state, expression of MxA was analyzed and a significant 21-fold higher upregulation was detected at 48 hours poststimulation with PUUV (P = .02) (Figure 1 ). The early type 1 IFN-induced antiviral state was inhibited after stimulation with DOBV.
IFN Type 1-Induced Antiviral State is Activated Earlier in PBMCs From
Patients With Mild PUUV Infection
To investigate whether the delayed type 1 IFN-induced antiviral state is associated with the severity of HFRS, acute-phase PBMCs from patients infected with DOBV and PUUV were stimulated. Expression of genes IFNβ, NFκB, STAT-1, and MxA was measured at 1, 9, and 24 hours poststimulation and the differences between patients with mild and severe DOBV or PUUV infection were investigated. Expression of IFNβ was significantly upregulated at 9 hours poststimulation in both groups of patients infected with DOBV. However, at 24 hours poststimulation a difference between the groups was observed, when upregulation of IFNβ was significantly higher in PBMCs of patients with mild infection (Figure 2) . With PUUV infection, expression of IFNβ at 9 hours poststimulation was significantly higher in PBMCs of patients with severe infection. In contrast, at 24 hours poststimulation with PUUV, expression of IFNβ was lower in PBMCs of patients with severe infection, but the difference between mild and severe group of patients was not statistically significant ( Figure 2 , Supplementary Table 2) . Upregulation of NFκB and STAT-1 was not detected poststimulation with DOBV (Supplementary Table 2) , whereas in the patients with severe PUUV infection significant upregulation of these genes was detected at 9 and 24 hours poststimulation. In patients with mild PUUV infection, only expression of STAT-1 was significantly upregulated at 24 hours poststimulation (Figure 3) . Furthermore, our results indicated that the antiviral state was activated earliest in patients with mild PUUV infection, where significant upregulation of MxA was detected at 9 and 24 hours poststimulation. In patients with severe PUUV infection, expression of MxA was upregulated only at 24 hours poststimulation (Figure 3) . Expression of MxA was not upregulated in patients with severe or mild DOBV infection (Supplementary Table 2 ).
IFN Type 1 Response of PBMCs From HFRS Patients After Disease Recovery Resembles that in PBMCs From Healthy Donors
To confirm the findings in acute-phase PBMCs, convalescent-phase cells from the same HFRS patients were stimulated and the response was similar to that observed in PBMCs from healthy donors (Supplementary Table 1 ). Expression of IFNβ was significantly higher in the convalescent PBMCs stimulated with PUUV than with DOBV at 48 hours poststimulation ( Figure 4A ). No significant difference in expression of NFκB was observed after PUUV or DOBV stimulation of PBMCs ( Figure 4A ). In convalescent phase PBMCs, PUUV but not DOBV activated the type 1 IFN-induced antiviral state (Supplementary Table 1) . Results showed a 6-fold higher expression of STAT-1 (P = .004) and 61-fold higher expression of MxA (P = .001) at 48 hours poststimulation with PUUV than with DOBV ( Figure 4A ). Expression of genes was compared between patients with severe and mild disease at 48 hours poststimulation and the only significant difference was in expression of MxA, which was 56-fold upregulated in PBMCs from patients with mild PUUV infection and was significantly 6-fold higher than in patients with severe infection ( Figure 4B ).
DISCUSSION
The type 1 IFN system is a major component of antiviral defense. Successful pathogens have evolved different strategies to suppress IFN production, to downregulate IFN signaling, and to block the action of antiviral proteins [3] . Pathogenic hantaviruses interact with early steps of the IFN antiviral pathway, which results in delayed transcription of IFNβ and other ISGs [14] [15] [16] . Some inconsistency in reports can be explained by the complexity of the signaling cascades that are downstream of the IFN and which can be triggered in different innate immune situations. The observed levels of IFNs and their receptors also depend on the type of cell investigated [16, 17] . In this study we focused on DOBV and PUUV inhibition of the IFN type 1-induced antiviral state in PBMCs as a possible explanation for HFRS severity.
In most cell types, infection with a virus triggers the activation of different classes of transcription factor and their translocation to the nucleus [18] . In our study, significant upregulation of NFκB was detected in stimulated PBMCs of patients with severe PUUV infection. DOBV, but not PUUV, has been demonstrated to inhibit NFκB activation by binding to importin-α proteins, thus preventing NFκB translocation and activation [19] . NFκB also controls the constitutive expression of IFN-β in uninfected cells and has a role only very early after infection [20] . Such findings could explain the inhibition of NFκB by DOBV in our study. Although upregulation of NFκB was not observed in PBMCs of patients with mild PUUV infection, the type 1 IFN-induced antiviral state was detected in these patients after stimulation with PUUV. Thus, NFκB probably has no role in type 1 IFN induction after stimulation of PBMCs with DOBV or PUUV. Our observation is supported by a previous finding suggesting that NFκB has no essential role in virus-induced type 1 IFN expression [21] . Our results also suggest that the potential role of IRF3 in the IFN type 1-induced antiviral state in PBMCs after stimulation with hantaviruses needs further investigation.
Immunological studies have shown that pathogenic hantaviruses suppress the early IFN-β response and that their ability to inhibit innate immunity varies according to their degree of pathogenicity. Both DOBV and PUUV inhibit IFN-β induction, but the inhibition reported for PUUV is only 10%-30% of the IFN response reduction [22] . Moreover, a strong interferon response has been shown to correlate with a milder clinical condition in dengue [23] . In accordance, our results indicate a lower expression of IFNβ at 24 hours poststimulation of PBMCs from patients with severe DOBV and PUUV infection in comparison with patients with mild disease. The inhibition of IFNβ observed between 9 and 24 hours poststimulation of PBMCs from patients with severe HFRS could be a possible explanation for a more severe clinical outcome.
The mechanism by which hantaviruses escape IFN responses possibly includes direct blocking of IFN induction and inhibition Asterisks represent significant differences between PBMCs stimulated with hantavirus and nonstimulated cells (P < .05). P values indicate significant differences between PBMCs stimulated with DOBV and PUUV (P < .05). Error bars show standard deviations. B, Fold changes for MxA at 48 hours poststimulation. PBMCs from PUUV-infected patients after disease recovery were stimulated with PUUV. P value indicates significant difference between stimulated PBMCs from convalescent patients with mild and severe PUUV infection (P < .05). Error bars show standard deviations.
of the IFN signaling pathway [16] . In our study, measurement of STAT-1 expression, which is activated by IFN and has a role in transcriptional activation of antiviral responses [24] , indicated significant upregulation of STAT-1 at 48 hours poststimulation with PUUV but not after stimulation with DOBV. STAT proteins use importin-α for their transportation to the nucleus [24] and, as has been shown for NFκB [19] , binding to importin-α could be an explanation for inhibition of STAT-1 by DOBV. As PBMCs are immune cells and the immune response of an individual is important for effective elimination of virus infection, we further investigated whether inhibition of the IFN type 1-induced antiviral state is related to HFRS severity. The antiviral effect of IFNs is mediated by IFN-induced proteins such as MxA, a protein that exhibits a broad spectrum of antiviral activity and is a key component of the antiviral state induced by IFN type 1 [4] . In our study, expression of MxA at 48 hours poststimulation of human PBMCs was significantly higher with PUUV than with DOBV. Activation of MxA involves IRF-3 nuclear translocation and it is known that pathogenic hantaviruses interfere with the IFR3 signaling pathway; thus, nuclear translocation of IRF3 is impaired following infection with hantaviruses [16, 25, 26] , which could support our observation that upregulation of MxA was not detected poststimulation with DOBV. It has been shown that pathogenic hantaviruses block early IFN responses but induce later high-level ISGs responses, 1-4 days after infection [14, 27] . It is possible that the antiviral state is activated later than 48 hours poststimulation of PBMCs with DOBV but this hypothesis was not tested in the present study, because of the decreased viability of PBMCs after 3 days poststimulation. In contrast, stimulation of PBMCs by PUUV activated the antiviral state and MxA was upregulated in PBMCs of patients with severe and mild PUUV infection. A further important factor in HFRS severity could be the time of induction of an antiviral state; this was detected earlier in stimulated PBMCs of patients with mild PUUV infection than in PBMCs of patients with severe infection.
The protective effect of neutralizing antibodies against reinfection with hantaviruses in humans was confirmed [17] . In our study it has been investigated whether there is any difference in the IFN type 1 response after disease recovery. DOBV or PUUV stimulation of PBMCs from convalescent samples indicated that PUUV, but not DOBV, activates the IFN type 1-induced antiviral state. Expression of IFNβ, STAT-1, and MxA was significantly upregulated at 48 hours poststimulation. Moreover, expression of MxA was significantly higher in PBMCs of patients with mild PUUV infection than with severe infection. The activated antiviral state in patients with mild PUUV infection probably restricted further viral replication after infection, which was confirmed by measurement of viral load in acutephase plasma samples. In our study, patients with severe PUUV infection had significantly higher viral loads in plasma samples than patients with mild infection (data not shown). Our results indicate that the higher activation of the IFN type 1-induced antiviral state possibly leads to a milder form of disease after PUUV infection.
In conclusion, our study clearly shows that DOBV inhibits the IFN type 1-induced antiviral state in human PBMCs. Inhibition was also observed after stimulation with PUUV, where activation of the antiviral state was detected at 48 hours poststimulation, although PBMCs are immune cells and a quick response to virus was presumed. Expression of IFNβ was delayed by both the hantaviruses studied and was even more inhibited in PBMCs of patients with severe HFRS. Such a delayed IFN type 1-induced antiviral state allows virus replication in body cells and could be one of the contributors to the severe clinical form of disease after PUUV infection. The complexity of the mechanism by which hantaviruses interfere with the host immune system requires further investigation for a better understanding of hantavirus immune pathogenesis.
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